# Provider Clinical Summary (PROVIDER-ONLY)

_Decision-support summary. Not a diagnosis, treatment recommendation, or dosing guidance._

**Patient:** Jordan Rivera (DEMO-001)
**Status:** active · **Risk level:** High Review Priority
**Latest assessment:** 2026-03-01T09:00:00+00:00 · **Last follow-up:** 2026-04-02T09:00:00+00:00

## Clinical snapshot
- Primary phenotype: babesia_pattern
- Secondary phenotype: neuroinflammation
- Recovery stage (derived): improving — Clinical improvement score 69 (56–69 vs baseline).
- Confidence: 52 (moderate)
- Top contributors: Air hunger / unexplained shortness of breath, Night sweats, Cyclical fevers, Headache

## Co-infection pattern scores
- bartonella: 13
- babesia: 50
- ebv: 0
- mold_cirs: 0
- mcas: 0

## Lab system scores
- inflammatory: 100
- immune: 0
- mitochondrial: 0
- hormonal: 0
- metabolic: 83
- nutritional: 11
- detoxification: 0
- neuroinflammatory: 89
- connective_tissue: 77
- Abnormal: Vitamin D (low), CRP (high), Ferritin (high), Fasting glucose (high), Fasting insulin (high), HbA1c (high), B12 (low)
- Missing: 40 marker(s)

## Safety review
- Overall: 68 (High Review Priority)
- High: cancer_history, reaction_history, reaction_history
- Missing safety info: allergy_history_confirmed, cancer_screening_confirmed, pregnancy_status_confirmed, infection_status_confirmed

## Outcomes
- Clinical improvement score: 69
- Functional improvement score: 68

## Provider review
- Status: reviewed
- Notes: Babesia-dominant presentation; metabolic + inflammatory lab signals; prior melanoma flagged for review. Trending up at day 30.

_Generated decision-support summary — physician review required. Source documents remain the source of truth._